Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-15

Clinical Trial Update: A Study to Evaluate Blood Levels of Bepirovirsen in Adult Participants With Severe or Moderate Kidney Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating blood levels of Bepirovirsen in adults with severe or moderate kidney disease. The sponsor is GlaxoSmithKline and the study targets Hep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bepirovirsen

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 1 | Status: RECRUITING